Stemline Therapeutics Inc

CIK 1264587 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Stemline Therapeutics Inc.

Recent SEC filings

FiledFormAccession number
Feb 12, 2021SC 13G/A0001580642-21-000680
Jun 22, 202015-12B0001104659-20-075492
Jun 16, 2020EFFECT9999999995-20-001437
Jun 16, 2020EFFECT9999999995-20-001438
Jun 16, 2020EFFECT9999999995-20-001439
Jun 10, 2020POS AM0001104659-20-071856
Jun 10, 202040001104659-20-071831
Jun 10, 2020SC 14D9/A0001104659-20-071781
Jun 10, 202040001104659-20-071835
Jun 10, 202040001104659-20-071839
Jun 10, 2020SC TO-T/A0001104659-20-071780
Jun 10, 202040001104659-20-071826
Jun 10, 20208-K0001104659-20-071766
Jun 10, 2020S-8 POS0001104659-20-071875
Jun 10, 202025-NSE0001354457-20-000244
Jun 10, 2020S-8 POS0001104659-20-071872
Jun 10, 202040001104659-20-071838
Jun 10, 202040001104659-20-071837
Jun 10, 2020S-8 POS0001104659-20-071879
Jun 10, 202040001104659-20-071841
Jun 10, 2020S-8 POS0001104659-20-071863
Jun 10, 202040001104659-20-071832
Jun 10, 2020POS AM0001104659-20-071855
Jun 10, 202040001104659-20-071825
Jun 10, 2020S-8 POS0001104659-20-071864